CEO, Jennifer Ernst, Speaking on Bioelectronic Medicine at CES Digital Health Summit San Francisco, December 30, 2019 – Tivic Health™ Systems Inc., a CES 2020 Innovation Award Honoree, will be at CES in Eureka Park booth 50527 demonstrating ClearUP® Sinus Pain Relief, the first bioelectronic solution for sinus pain cleared by the FDA. According to […]
ClearUP Relieves Sinus Pain from Seasonal and Year Round Allergies San Francisco, November 22, 2019 – ClearUP® Sinus Pain Relief from Tivic Health™ Systems Inc. was named today to TIME’s 2019 Best Inventions in the healthcare category. Launched in September, ClearUP is available without a prescription and is FDA cleared to treat sinus pain due […]
San Francisco, November 18, 2019 – Jennifer Ernst, CEO of Tivic Health™ Systems Inc., a commercial phase bioelectronic company, will present at the MedTech Strategist Innovation Summit San Francisco 2019 Conference, taking place November 18-19 at the Hyatt Regency in Burlingame. The Innovation Summit will feature presentations by more than 30 medtech start-ups showcasing their […]
San Francisco, November 14, 2019 –Tivic Health™ Systems Inc., a commercial phase bioelectronic company, today announced it has received ISO 13485:2016 certification for its quality management system (QMS), following review by the British Standards Institute (BSI). ISO 13485:2016 is an internationally recognized quality standard for the medical device industry and demonstrates Tivic Health’s dedication to […]
ClearUP® Sinus Pain Relief Honored in Health and Wellness Category NEW YORK, Nov. 7, 2019 /PRNewswire/ — Tivic Health™ Systems Inc. first product, ClearUP® Sinus Pain Relief, has been selected as a CES 2020 Innovation Awards Honoree. ClearUP, an example of bioelectronics, is a drug-free, non-invasive device that uses neuromodulation to treat sinus pain from allergic rhinitis – seasonal and year-round […]
Tivic Health’s ClearUP Sinus Pain Relief Begins Shipping A First Of Kind Bioelectronic Device, ClearUP Is Available Over-The-Counter To Treat Allergy-Related Sinus Pain
SAN FRANCISCO, Sept. 16, 2019 /PRNewswire/ — Tivic Health™ Systems Inc. a commercial phase bioelectronic company, today announced it has begun shipping ClearUP® Sinus Pain Relief, a game-changing way to treat sinus pain due to allergic rhinitis – seasonal and year round allergies. A small, handheld drug free device, ClearUP uses microcurrent technology that works […]
SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ — Tivic Health™ Systems Inc. today announced that, ClearUP® Sinus Pain Relief, a game-changing treatment for sinus pain due to allergic rhinitis, has been named a finalist at the Health 2.0 Annual Launch! competition. Health 2.0 will take place September 16-18 at Santa Clara Convention Center and the Launch! […]
Tivic Health heads to American Academy of Otolaryngic Allergy and American Rhinologic Society events in New Orleans, September 13-15
San Francisco, September 4, 2019 – Tivic Health™ Systems Inc., a commercial phase bioelectronic company, will be exhibiting ClearUP® Sinus Pain Relief, a game-changing treatment for sinus pain, at the American Academy of Otolaryngic Allergy (AAOA) and American Rhinologic Society (ARS) Annual Meetings in New Orleans, Sept 13-15. Tivic Health will exhibit at AAOA booth […]
Tivic Health Named Finalist in MedTech Insight Awards Category: Most Innovative Team or Innovator of the Year Category
San Francisco, August 20, 2019 – Tivic Health™ Systems Inc., a commercial phase bioelectronic company, has been named a finalist in the Medtech Insight Awards honoring companies and executives who have made significant contributions in the device and diagnostic space. Tivic Health was named a finalist in the category: Most Innovative Team or Innovator or the Year. Winners will be announced at the MedTech Conference on September 23 in Boston.
Tivic Health Raises $8 Million Series Seed Round Funds to be Used for Fall Launch of ClearUP® Sinus Pain Relief
Tivic Health™ Systems, a bioelectronic medical device company that treats chronic conditions, today announced an $8 million Series Seed investment from Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments, a physician network and individual investors. The company has raised funds in a series of tranches, the most recent of which closed last week.